# Effect of Gemigliptin or Acarbose on Endothelial Function in Type 2 DM Patients

> **NCT02500329** · PHASE4 · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 54 (estimated)

## Conditions studied

- Endothelial Function
- Type 2 Diabetes
- Gemigliptin
- Acarbose

## Interventions

- **DRUG:** Gemigliptin
- **DRUG:** Acarbose

## Key facts

- **NCT ID:** NCT02500329
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2015-12
- **Final completion:** —
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2015-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02500329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02500329, "Effect of Gemigliptin or Acarbose on Endothelial Function in Type 2 DM Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02500329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*